Dostarlimab-gxly demonstrated high rates of sustained clinical complete response that allowed eligible patients to avoid chemotherapy, radiation, and surgery.
The application for the next-generation mitomycin formulation is supported by 3-month complete response data from the phase 3 UTOPIA trial.
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for rezafungin (Rezzayo ®) for the prophylaxis of invasive fungal disease.
The Food and Drug Administration (FDA) has expanded the approval of Ryzumvi ® (phentolamine ophthalmic solution 0.75%) to include the treatment of presbyopia in adults.
Strong recommendations made for semiannual surveillance for HCC, testing and vaccination for hepatitis A and B.
Researchers found that mean serum potassium was 4.16 and 4.18mmol/L in the group assigned DASH-patterned groceries and the self-directed group, respectively.
HealthDay News — Structured support may attenuate weight gain after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a study published online October 7 in Obesity ...
HealthDay News — Undeclared pharmacologically active ingredients (UPAIs) are detected in one-third of over-the-counter (OTC) skin products marketed online, according to a study published online ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results